Empowering Patient Perspectives in Influenza Research and Management: A Comprehensive Review of Patient-Reported Outcomes - Report - MDSpire

Empowering Patient Perspectives in Influenza Research and Management: A Comprehensive Review of Patient-Reported Outcomes

  • By

  • Elizabeth Meda-Monzón

  • Paloma Muñoz-Aguirre

  • Barbara Aída Flores-Aldana

  • Chad Gwaltney

  • José Bartelt-Hofer

  • February 21, 2026

  • 0 min

Share

Clinical Report: Empowering Patient Perspectives in Influenza Research and Management

Overview

This comprehensive review highlights the importance of Patient-Reported Outcomes (PROs) in influenza research, emphasizing their role in capturing patient experiences and improving healthcare delivery. The study identifies existing PRO instruments and gaps in their application, providing recommendations for better integration in clinical practice.

Background

Influenza is a significant global health concern, causing substantial morbidity and mortality each year. The disease not only leads to severe clinical outcomes but also imposes a considerable symptomatic burden that affects patients' quality of life. Understanding patient perspectives through PROs is essential for enhancing treatment strategies and ensuring patient-centered care.

Data Highlights

No numerical data was provided in the source material.

Key Findings

  • Influenza causes an estimated 294,000 to 518,000 deaths globally each year.
  • Patient-reported outcomes (PROs) capture vital aspects of patient experiences, including health status and quality of life.
  • Generic PRO instruments may not adequately reflect disease-specific impacts, necessitating targeted measures for influenza.
  • Existing PRO instruments for influenza include the FLU-PRO©, which has been validated for use in influenza-positive patients.
  • Healthcare professionals can leverage PROs to provide more personalized care and inform public health decisions.

Clinical Implications

Incorporating PROs into influenza research can enhance understanding of patient experiences and treatment impacts. This approach can lead to improved patient-centered care and more informed public health strategies, ultimately reducing the burden of influenza.

Conclusion

The integration of Patient-Reported Outcomes in influenza research is crucial for capturing the full impact of the disease on patients. Addressing the identified gaps in PRO application can significantly enhance patient care and treatment outcomes.

Related Resources & Content

  1. CDC, CDC, 2025 -- Summary of Recommendations for Influenza Vaccination
  2. The Journal of Infectious Diseases, 2023 -- Evolving Patient Care Strategies for Influenza in the Aftermath of the COVID-19 Pandemic: A Position Statement
  3. The Journal of Infectious Diseases, 2023 -- Adaptive Platform Trials for Evaluating Treatments in Hospitalized Influenza Patients
  4. The ASCO Post, 2019 -- Patient-Centered Initiatives at the FDA
  5. Drug Safety, 2021 -- Integrating Patient Perspectives on Benefit-Risk: The Patient Global Impression of Benefit–Risk (PGI-BR) in Evaluating New Therapeutics
  6. CDC, CDC -- Influenza Antiviral Medications: Summary for Clinicians
  7. PMC, 2018 -- Reliability, Validity, and Responsiveness of InFLUenza Patient-Reported Outcome (FLU-PRO©) Scores In Influenza Positive Patients
  8. https://www.cdc.gov/flu/media/pdfs/2025-2026-summary-of-recommendations.pdf
  9. Influenza Antiviral Medications: Summary for Clinicians | Influenza (Flu) | CDC
  10. Reliability, Validity, and Responsiveness of InFLUenza Patient-Reported Outcome (FLU-PRO©) Scores In Influenza Positive Patients - PMC

Original Source(s)

Related Content